Hosted on MSN6d
JMP Securities Downgrades MacroGenics (MGNX)
Fintel reports that on November 7, 2024, JMP Securities downgraded their outlook for MacroGenics (NasdaqGS:MGNX) from Market ...
Ibotta price target lowered to $85 from $111 at JMP Securities
JMP Securities lowered the firm’s price target on Ibotta (IBTA) to $85 from $111 and keeps an Outperform rating on the shares. Ibotta ...
JMP Securities Remains a Buy on Similarweb (SMWB)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Similarweb (SMWB – Research Report) today and set a price target of ...
ETF Daily News5d
JMP Securities Increases Arbutus Biopharma (NASDAQ:ABUS) Price Target to $5.00
Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...
Nasdaq6d
Evolent Health price target lowered to $27 from $43 at JMP Securities
JMP Securities analyst Constantine Davides lowered the firm’s price target on Evolent Health (EVH) to $27 from $43 and keeps a Market Perform rating on the shares following Q3 results.
Nasdaq6d
AMN Healthcare price target lowered to $47 from $57 at JMP Securities
JMP Securities analyst Constantine Davides lowered the firm’s price target on AMN Healthcare (AMN) to $47 from $57 and keeps an Outperform rating on the shares following Q3 results. Unfulfilled ...
AviationPros6d
JFK Millennium Partners Completes Nearly $2B Bond Issuance for JFK Terminal 6 Redevelopment
Terminal 6 is a key component of the Port Authority of New York and New Jersey's $19 billion transformation of JFK International Airport into a world-class gateway, with two new terminals, two ...